M. Srour

发表

Current Limitations and Perspectives of Chimeric Antigen Receptor-T-Cells in Acute Myeloid Leukemia

H. Einsele, I. Yakoub-Agha, M. Hudecek, 2021, Cancers.

Single-agent 5-azacytidine as post-transplant maintenance in high-risk myeloid malignancies undergoing allogeneic hematopoietic cell transplantation

B. Quesnel, I. Yakoub-Agha, A. Duhamel, 2022, Annals of Hematology.

Impact of Defibrotide in the Prevention of Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplantation

I. Yakoub-Agha, N. Simon, P. Odou, 2022, The Annals of Pharmacotherapy.

Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis

N. Kröger, M. Robin, P. Chevallier, 2021, Bone Marrow Transplantation.

[Indications and management of hematologic microtransplantation: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

P. Chevallier, I. Yakoub-Agha, C. Picard, 2020, Bulletin du cancer.

COVID-19 paraclinical diagnostic tools: Updates and future trends

Tamim Alsuliman, Sawsan Ismail, Rand Sulaiman, 2020, Current Research in Translational Medicine.

Clinical and economic impact of treated CMV infection in adult CMV‐seropositive patients after allogeneic hematopoietic cell transplantation

P. Chevallier, I. Yakoub-Agha, D. Blaise, 2020, Journal of medical virology.

A review of potential treatments to date in COVID-19 patients according to the stage of the disease

Tamim Alsuliman, Lugien Alasadi, M. Srour, 2020, Current Research in Translational Medicine.

Management of adults and children undergoing chimeric antigen receptor T-cell therapy: best practice recommendations of the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)

M. Kersten, H. Einsele, N. Kröger, 2019, Haematologica.

On Behalf of the SFGM-TC: Retrospective Comparison of Reduced and Higher Intensity Conditioning for High-Risk Myelodysplastic Syndrome Treated With Allogeneic Stem-Cell Transplantation.

M. Robin, J. Bay, E. Forcade, 2021, Clinical lymphoma, myeloma & leukemia.

Measurable residual disease, FLT3‐ITD mutation, and disease status have independent prognostic influence on outcome of allogeneic stem cell transplantation in NPM1‐mutated acute myeloid leukemia

N. Kröger, M. Labopin, D. Blaise, 2022, Cancer medicine.

The promising efficacy of a risk-based letermovir use strategy in CMV-positive allogeneic hematopoietic cell recipients

I. Yakoub-Agha, K. Faure, E. Alidjinou, 2022, Blood advances.

Haemophagocytic lymphohistiocytosis following allogeneic hematopoietic cell transplantation from mismatched unrelated donors associated with low CD34 and CD3 cell counts in the graft

I. Yakoub-Agha, V. Coiteux, C. Ballot, 2022, Bone Marrow Transplantation.

Allogeneic hematopoietic stem cell transplantation from unmanipulated haploidentical donor and unrelated cord blood for T-cell lymphoma: a retrospective study from the Société Francophone de Greffe de Moelle et de Therapie Cellulaire

M. Robin, P. Chevallier, D. Blaise, 2021, Bone Marrow Transplantation.

The concurrent administration of imatinib with extracorporeal photopheresis leads to complete and durable responses in patients with refractory sclerotic type chronic graft-versus-host disease.

I. Yakoub-Agha, V. Coiteux, J. Gauthier, 2020, Current research in translational medicine.

Outcomes after allogeneic hematopoietic stem cell transplantation for adults with primary mediastinal B cell lymphoma: a SFGM-TC and LYSA study

P. Chevallier, M. Béné, R. Gressin, 2022, Acta oncologica.

A novel tetracycline-controlled transactivator–transrepressor system enables external control of oncolytic adenovirus replication

H. Fechner, W. Hillen, H. Scherübl, 2003, Gene Therapy.

Successful and safe response to ibrutinib alone in treating relapsed Waldenström macrogobulinemia and related acquired von Willebrand syndrome: an option to consider

S. Susen, A. Bauters, A. Dupont, 2022, Leukemia & lymphoma.

Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT

J. Bourhis, M. Labopin, A. Nagler, 2023, Bone Marrow Transplantation.

Nilotinib efficacy and safety as salvage treatment following imatinib intolerance and/or inefficacy in steroid refractory chronic graft-versus-host-disease (SR-cGVHD): a prospective, multicenter, phase II study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy

P. Chevallier, I. Yakoub-Agha, G. Guillerm, 2023, Bone Marrow Transplantation.

Alterations of Some MicroRNAs Expression in Hepatocellular Carcinoma Cell Lines by Sodium Butyrate

M. Srour, A. El-Wahab, Medhat Salah El-Halawany Mona Mohamed Mostafa, 2019, The Medical Journal of Cairo University.

Daratumumab is effective in the relapsed or refractory systemic light‐chain amyloidosis but associated with high infection burden in a frail real‐life population

T. Facon, E. Boyle, S. Manier, 2019, British journal of haematology.

[Graft failure, poor graft function erythroblastopenia: Actualization of definitions, diagnosis and treatment: Recommendations of the Francophone Society of Bone Marrow Transplantation and cell therapy (SFGM-TC) 2021].

G. Guillerm, F. Giannotti, Tamim Alsuliman, 2022, Bulletin du cancer.

Safety and efficacy of nivolumab in patients who failed to achieve a complete remission after CD19-directed CAR T-cell therapy in diffuse large B cell lymphoma.

I. Yakoub-Agha, E. Alidjinou, F. Morschhauser, 2023, British Journal of Haematology.

High frequency of cutaneous eruptions within the first year after allogeneic hematopoietic stem cell transplantation

B. Catteau, V. Coiteux, D. Staumont-Sallé, 2023, JEADV Clinical Practice.

Three-dimensional sonographic diagnosis of abdominal wall endometriosis: a useful tool?

A. Khaddage, G. Chene, M. Varlet, 2011, Fertility and Sterility.

Efficacy and Safety of Daratumumab in a Frail Real-Life Relapsed or Refractory Systemic Light-Chain Amyloidosis Population (AL): Report on 15 Cases from the North of France

T. Facon, A. Simonnet, E. Boyle, 2018, Blood.

[Indications and management of hematologic microtransplantation: Recommendations of the French Society of Bone Marrow transplantation and cellular Therapy (SFGM-TC)].

P. Chevallier, I. Yakoub-Agha, C. Picard, 2020, Bulletin du cancer.

G. Guillerm, F. Giannotti, Tamim Alsuliman, 2022, Bulletin du cancer.

Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cell transplantation in recipients of matched sibling or 10/10 HLA matched unrelated donors: final analysis of a randomized, open-label, multicenter, phase 2 trial

M. Labopin, D. Blaise, M. Mohty, 2024, Blood cancer journal.